A winning strategy is essential to reach or accomplish goals in pharmaceutical industry. However, maintaining the excellence of Strategic Drug Development Services is a necessary stipulation for the Strategic evolution for Pharma companies. The technologies leading to Pharmaceutical regulatory strategy and Pharmaceutical strategic developments are at the limits of human knowledge. The huge size of the companies, organizations and the complexities of their technologies and processes present many challenges. On the other hand, strategy development and distribution system is highly costly to implement. The effective Pharma strategies can help to generate business exposure, relationship building, and market research. Thus, they are important initiatives to boom overall business in the long term.
Regulatory authorities are critical to the development and commercialisation of drugs as they govern the safety
CGT stands at the forefront of personalised medicine revolutionising healthcare by modifying patients
Cell culture media is a significant driver of productivity within biopharmaceutical manufacturing processes
Approximately million people worldwide are living with a rare disease and about half of those affected by rare diseases are children
In the first article in this series The Glocalisation Challenge I differentiated between astute and nave glocalisers and in this fourth and final article
The pharmaceutical industry is known for its complexity and strict regulations making it challenging for companies to maintain highquality standards while still remaining competitiveThe pharmaceutical industry is known for its complexity and strict regulations making it challenging for companies to maintain highquality standards while still remaini...
The pharma sectors ongoing transformation has prompted most pharma and biotech players to focus on launching new products developing innovative technologies virtual clinical trials and rapid digitalisation These initiatives are proving to be quite challenging
The continuous digital transformation including blockchain technology for greater traceability increasing attention to sustainability and a move towards
Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA
The first article in this series began from the premise that exploiting global markets creates a dilemma for pharmaceutical and other life sciences companies which I called the glocalisation challenge